OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Facile discovery of surrogate cytokine agonists
Michelle Yen, Junming Ren, Qingxiang Liu, et al.
Cell (2022) Vol. 185, Iss. 8, pp. 1414-1430.e19
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

The JAK-STAT pathway at 30: Much learned, much more to do
Rachael L. Philips, Yuxin Wang, HyeonJoo Cheon, et al.
Cell (2022) Vol. 185, Iss. 21, pp. 3857-3876
Open Access | Times Cited: 373

Engineering cytokine therapeutics
Jeroen Deckers, Tom Anbergen, Ayla M. Hokke, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 4, pp. 286-303
Open Access | Times Cited: 119

The present and future of bispecific antibodies for cancer therapy
Christian Klein, Ulrich Brinkmann, Janice M. Reichert, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 4, pp. 301-319
Closed Access | Times Cited: 119

Emerging principles of cytokine pharmacology and therapeutics
Robert A. Saxton, Caleb R. Glassman, K. Christopher García
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 1, pp. 21-37
Open Access | Times Cited: 110

Strategies to therapeutically modulate cytokine action
Warren J. Leonard, Jian‐Xin Lin
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 10, pp. 827-854
Closed Access | Times Cited: 56

Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development
Lin Tang, Sheng Pan, Xuyong Wei, et al.
Molecular Therapy (2023) Vol. 31, Iss. 11, pp. 3146-3162
Open Access | Times Cited: 43

A pivotal decade for bispecific antibodies?
Marlena Surowka, Christian Klein
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 19

Boronic Acid-Decorated Carbon Dot-Based Semiselective Multichannel Sensor Array for Cytokine Discrimination and Oral Cancer Diagnosis
Jie Gao, Xiaohua Zhu, Ying Long, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 4, pp. 1795-1802
Closed Access | Times Cited: 18

Structure of the Wnt–Frizzled–LRP6 initiation complex reveals the basis for coreceptor discrimination
Naotaka Tsutsumi, Sun‐Hee Hwang, Deepa Waghray, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 11
Open Access | Times Cited: 26

The JAK-STAT pathway: from structural biology to cytokine engineering
You Lv, Jianxun Qi, Jeffrey J. Babon, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13

i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists
Matthew G. Romei, Brandon Leonard, Zachary Katz, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8

The IL-2A receptor pathway and its role in lymphocyte differentiation and function
Yuqian Li, Xue Li, Xiaokun Geng, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 67, pp. 66-79
Closed Access | Times Cited: 31

Lessons from Long COVID: working with patients to design better research
Nisreen A Alwan
Nature reviews. Immunology (2022) Vol. 22, Iss. 4, pp. 201-202
Open Access | Times Cited: 30

Next generation of multispecific antibody engineering
Dániel Kéri, Matt Walker, Isha Singh, et al.
Antibody Therapeutics (2023) Vol. 7, Iss. 1, pp. 37-52
Open Access | Times Cited: 20

Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses
Xuan Yang, Rebekah J. Dickmander, Armin Bayati, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 7, pp. 1937-1950
Open Access | Times Cited: 23

30 years of nanobodies – an ongoing success story of small binders in biological research
Desiree I. Frecot, Theresa Froehlich, Ulrich Rothbauer
Journal of Cell Science (2023) Vol. 136, Iss. 21
Open Access | Times Cited: 14

Apelin receptor dimer: Classification, future prospects, and pathophysiological perspectives
Shujuan Hu, Dexiu Wang, Wenkai Liu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 6, pp. 167257-167257
Closed Access | Times Cited: 5

The β Common Cytokine Receptor Family Reveals New Functional Paradigms From Structural Complexities
Winnie L. Kan, Claire M. Weekley, Tracy L. Nero, et al.
Immunological Reviews (2025) Vol. 329, Iss. 1
Closed Access

Matchmaking at the cell surface using bispecifics to put cells on their best behavior
C. Driscoll, Mark Howarth
Current Opinion in Biotechnology (2025) Vol. 92, pp. 103267-103267
Open Access

Redirecting immune signaling with cytokine adaptors
Gita C. Abhiraman, Karsten D. Householder, Grayson E. Rodriguez, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Research progress on nanobodies in the diagnosis and treatment of natural toxin poisoning
Xiwei Wang, Zenglin Yin, Nan Liu, et al.
Nano Today (2025) Vol. 62, pp. 102711-102711
Closed Access

Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies
Sahar Balkhi, Giorgia Bilato, Andrea De Lerma Barbaro, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 69-69
Open Access

Taming interleukin‐12: Engineering of bispecific antibody‐based IL‐12 mimetics with biased agonism capacities
Britta Lipinski, Laura Unmuth, Paul Arras, et al.
Protein Science (2025) Vol. 34, Iss. 3
Open Access

Induced proximity at the cell surface
Nicholas A. Till, Muthukumar Ramanathan, Carolyn R. Bertozzi
Nature Biotechnology (2025)
Closed Access

Page 1 - Next Page

Scroll to top